Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer's disease

A Akhtar, SP Sah - Neurochemistry international, 2020 - Elsevier
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Its major
pathological hallmarks, neurofibrillary tangles (NFT), and amyloid-β plaques can result from …

Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment

VL Martucci, K Pacak - Current problems in cancer, 2014 - Elsevier
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors that arise from the
chromaffin cells of the adrenal glands. Paragangliomas (PGLs), the extra-adrenal …

Effects of metformin on endometrial cancer: Systematic review and meta-analysis

CG Meireles, SA Pereira, LP Valadares, DF Rêgo… - Gynecologic …, 2017 - Elsevier
Background Endometrial cancer is one of the most common gynecological cancers, which is
frequently preceded by atypical endometrial hyperplasia, a premalignant lesion. Metformin …

The roles of PDGF in development and during neurogenesis in the normal and diseased nervous system

K Funa, M Sasahara - Journal of Neuroimmune Pharmacology, 2014 - Springer
The four platelet-derived growth factor (PDGF) ligands and PDGF receptors (PDGFRs), α
and β (PDGFRA, PDGFRB), are essential proteins that are expressed during embryonic and …

The PI3K/Akt pathway in tumors of endocrine tissues

HL Robbins, A Hague - Frontiers in endocrinology, 2016 - frontiersin.org
The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is a key driver in carcinogenesis.
Defects in this pathway in human cancer syndromes such as Cowden's disease and Multiple …

Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next …

G Lotfy, YMA Aziz, MM Said, H El Sayed, H El Sayed… - Bioorganic …, 2021 - Elsevier
Despite the achieved progress in developing efficient MDM2-p53 protein-protein interaction
inhibitors (MDM2 inhibitors), the acquired resistance of tumor cells to such p53 activators …

The VHL/HIF axis in the development and treatment of pheochromocytoma/paraganglioma

S Peng, J Zhang, X Tan, Y Huang, J Xu… - Frontiers in …, 2020 - frontiersin.org
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors
originating from chromaffin cells in the adrenal medulla (PCCs) or extra-adrenal sympathetic …

Pheochromocytoma: a genetic and diagnostic update

LB Mercado-Asis, KI Wolf, I Jochmanova, D Taïeb - Endocrine practice, 2018 - Elsevier
ABSTRACT Objective: Pheochromocytomas and paragangliomas (PPGLs) are
neuroendocrine tumors derived from adrenal or extra-adrenal locations, respectively. Upon …

Autophagy inhibition enhances sunitinib efficacy in clear cell ovarian carcinoma

L DeVorkin, M Hattersley, P Kim, J Ries… - Molecular Cancer …, 2017 - AACR
Clear cell ovarian carcinoma (CCOC) is an aggressive form of epithelial ovarian cancer that
exhibits low response rates to systemic therapy and poor patient outcomes. Multiple studies …

Antiangiogenic therapies for pheochromocytoma and paraganglioma

C Jimenez, S Fazeli… - Endocrine-related …, 2020 - erc.bioscientifica.com
Metastatic pheochromocytomas and paragangliomas are rare, highly vascular tumors that
spread primarily to the lymph nodes, skeletal tissue, lungs, and liver. Tumor morbidity is …